StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$90.20−1.34 (-1.46%)

Close on Nov 19, 2026Market cap $4.26BP/E –Yield –

BillionToOne revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

BillionToOne's revenue for the twelve months ending Sep 30, 2026 was $436.87M, up 71.9% year over year. For fiscal 2025 it was $305.11M, up 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$305.11M+100.0%
FY2024Dec 31, 2024$152.58M+112.7%
FY2023Dec 31, 2023$71.73M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$122.98M+47.2%
Q2 FY2026Jun 30, 2026$109.45M+64.4%
Q1 FY2026Mar 31, 2026$108.39M+83.8%
Q4 FY2025Dec 31, 2025$96.05M+113.1%
Q3 FY2025Sep 30, 2025$83.52M+117.4%
Q2 FY2025Jun 30, 2025$66.57M–
Q1 FY2025Mar 31, 2025$58.96M–
Q4 FY2024Dec 31, 2024$45.08M–
Q3 FY2024Sep 30, 2024$38.42M–

More BillionToOne figures

See a number that looks wrong?